logo

For the Inventor, By the Inventor

Princeton, NJ, United States of America

John C Seed

This inventor holds 6 USPTO granted patents. Top assignees: Heart Care Partners, Other. Active years: 1990-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John C Seed. Retrieved from https://idiyas.com/inventor/john-c-seed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 1.7

ph-index = 4

Forward Citations = 76(Granted Patents)


Company Filing History:

goldMedal4 out of 4 
 
Heart Care Partners
 patents
silverMedal2 out of 834,513 
Other
 patents

Years Active: 1990-2006

Loading Chart...
6 patents (USPTO):Explore Patents
1. 7109206 - Methods and compositions for the rapid and enduring relief of inadequate myocardial function (2006-09-19),
2. 6159993 - Methods and compositions for the rapid and enduring relief of inadequate (2000-12-11),
3. 615999 - Methods and compositions for the rapid and enduring relief of inadequate (2000-12-12),
4. 5861399 - Methods and compositions for the rapid and enduring relief of inadequate (1999-01-19),
5. 5656592 - Use of relaxin as an analgesic and palliative for intractable pain (1997-08-12),
6. 4895845 - Method of assisting weight loss (1990-01-23),

Title: Innovations by John C Seed

Introduction

John C Seed is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of cardiovascular health, holding a total of six patents. His work focuses on methods and compositions aimed at improving myocardial function and reducing heart disease.

Latest Patents

Among his latest patents, John C Seed has developed methods and compositions for the rapid and enduring relief of inadequate myocardial function. These innovations disclose methods for reducing coronary artery stenosis, restoring blood flow to infarcted myocardium, and improving myocardial perfusion. His inventions involve administering compounds that include eicosapentaenoic acid or docosahexaenoic acid, combined with cholesterol-lowering therapeutics and dietary restrictions. The goal is to achieve a serum LDL concentration of less than 75 mg/dl, preferably less than 55 mg/dl. One particular method includes a combination of marine lipids and cholesterol synthesis or transfer inhibitors, with optional inclusion of aspirin and/or niacin. Additionally, his methods may involve the administration of buspirone for treating heart disease.

Career Highlights

John C Seed has worked with various companies, including Heart Care Partners. His innovative approaches have contributed to advancements in cardiovascular treatments and have the potential to improve patient outcomes significantly.

Collaborations

John has collaborated with Brian Seed, further enhancing the impact of his inventions in the medical field.

Conclusion

John C Seed's contributions to cardiovascular health through his patents demonstrate his commitment to innovation and improving patient care. His work continues to influence the field and offers hope for better treatment options for heart disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…